Pathogenic mechanisms in neonatal GBS infection.
D000268:Adhesiveness; D000942:Antigens, Bacterial; D003167:Complement Activation; D006801:Humans; D006819:Hyaline Membrane Disease / Q000209:etiology; D007111:Immunity, Cellular; D007231:Infant, Newborn; D008070:Lipopolysaccharides; D008581:Meningitis / Q000382:microbiology; D009439:Neuraminidase / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism; D010712:Phosphatidic Acids / Q000502:physiology; D012141:Respiratory Tract Infections / Q000382:microbiology; D012703:Serotyping; D012794:Sialic Acids / Q000502:physiology; D013290:Streptococcal Infections / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D013292:Streptococcus agalactiae / Q000145:classification / Q000276:immunology / Q000472:pathogenicity*; D013682:Teichoic Acids / Q000502:physiology; D014774:Virulence
D000942:Antigens, Bacterial; D008070:Lipopolysaccharides; D010712:Phosphatidic Acids; D012794:Sialic Acids; D013682:Teichoic Acids; C009900:lipoteichoic acid; D009439:Neuraminidase; D010447:Peptide Hydrolases